Beruflich Dokumente
Kultur Dokumente
DOI 10.1007/s00268-007-9206-0
Abstract
Background Despite the advances in neonatal surgery,
the outcome of neonatal intestinal obstruction (NIO) in
many developing countries has been reported to be poor.
This study describes the trends in NIO, including the
contributory factors in southeast Nigeria.
Methods We performed a comparative analysis of 128
consecutive NIO managed from January 1996 to December
2005 at the University of Nigeria Teaching Hospital,
Enugu, in southeast Nigeria.
Results Fifty-five (43.0%) neonates were managed in the
first 5 years (group A) and 73 (57.0%) in the last 5 years
(group B). Etiology of obstruction did not vary significantly in the two groups. Average duration of symptoms
before presentation fell from 5.9 days (group A) to 4.7 days
(group B). With exception of Hirschsprungs disease (HD),
all other cases required operative treatment. In HD,
colostomy rate declined from 44.4% (group A) to 26.7%
(group B). More neonates in group B were managed with
general anesthesia and perioperative third-generation
cephalosporin antibiotics (p \ 0.01). While complication
rate did not vary significantly in the two groups (group A,
42%; group B, 40.3%), survival improved (group A,
61.8%; group B, 72.6%). Earlier presentation, improved
S. O. Ekenze U. O. Ezomike
Subdepartment of Paediatric Surgery, University of Nigeria
Teaching Hospital, Enugu, Nigeria
S. N. Ibeziako
Newborn Special Care Unit, Department of Paediatrics,
University of Nigeria Teaching Hospital, Enugu, Nigeria
S. O. Ekenze (&)
Department of Surgery, University of Nigeria Teaching Hospital,
Enugu, Nigeria
e-mail: soekenze@yahoo.com
manpower, and use of potent antibiotics may have contributed to the improved outcome. Challenges in the form
of lack of neonatal intensive care facilities and dearth of
qualified personnel persist.
Conclusion There is a trend toward earlier presentation
and increased survival of babies with NIO in our setting.
Improving the existing facilities and trained manpower,
and establishing collaboration with centers that have
excellent results may further encourage the trend.
123
2406
Group A
Etiology of NIO
Anorectal malformation
22
33
55 (43.0) 0.555
Hirschsprungs disease
15
24 (18.7) 0.548
30
Jejunoileal atresia
11
20 (15.6) 0.841
25
11 (8.6) 0.129
Duodenal atresia
10 (7.8) 0.558
Obstructed hernia
8 (6.3) 0.475
Group B
40
35
Number of neonates
20
15
10
5
0
0 - 7 days
8 - 15 days
16- 22 days
23 - 30 days
Age
Fig. 1 Age distribution of the 128 neonates with intestinal obstruction at presentation
123
Results
The age of the neonates ranged from 2 to 27 days (overall
mean age = 9.8 days; group A = 10.3 days, group B = 9.4
days). Twenty-seven (21.1%, 10 in group A, 17 in group B)
were referred from the NSCU and 101 (78.9%, 45 in group
A, 56 in group B) from the peripheral hospitals. Figure 1
show the age distribution of the neonates at presentation.
2407
Group A (n = 55)
Group B (n = 73)
p value
5.2 days
5.9 days
4.7 days
0.092
Operation anesthesia
112 (87.5%)
50 (90.9%)
62 (84.9%)
0.311
General
106 (94.6%)
44 (88.0%)
62 (100%)
0.006*
Local
6 (5.4%)
6 (12.0%)
0 (0%)
0.006*
48 (42.9%)
39 (78.0%)
9 (14.5%)
0.000*
64 (57.1%)
11 (22.0%)
53 (85.5%)
0.000*
Significant value
Management trends
The average duration of symptoms before presentation was
5.9 days (range = 1-21 days) in group A and 4.7 days
(range 1 17 days) in group B. Overall, 112 (87.5%) of the
neonates (50 in group A, 62 in group B) had operative
treatment. The remaining 16 (12.5%) were cases of HD (5
in group A, 11 in group B) whose obstructions responded
to nonoperative treatment.
In terms of anesthesia, 100% of the operations in group
B were done with general anesthesia as opposed to 88% in
group A. The rest (12.0%) of the neonates in group A were
operated on with local anesthesia. The number of qualified
anesthesiologists increased from one in the first 5 years to
three in the last 5 years. Also increased was the number of
residents in anesthesia, from 4 in the first 5 years to 13 in
the last 5 years. From 2001, pulse oximetry was routinely
used in the management of NIO, unlike the period prior to
2001 during which it was used in only 40% of the cases.
The number of qualified pediatric surgeons and neonatologists also increased from two and three, respectively,
before 2001 to three and four, respectively, from 2001.
There are emerging trend toward the use of perioperative third-generation cephalosporins in group B compared
to group A [used in 53 (85.5%) neonates in group B
compared to 11 (22.0%) in group A]. The rest of the
neonates [9 (14.5%) in group B and 39 (78.0%) in group A]
were managed with an ampicillin-cloxacillin combination
and metronidazole. In the last two years of the study period, only third-generation cephalosporin was used. Table 2
shows the trend in management between the groups of
neonates.
Postoperative complications
There were 46 complications (21 in group A, 25 in group
B). The complication rate in group A was 42.0%, while the
rate in group B was 40.3%. Table 3 summarizes the
complications in the 112 neonates operated for intestinal
obstruction.
123
2408
Complications
Overall (n = 112)
12 (24.0%)
14 (22.6%)
0.859
4/20 (20.0%)
7/29 (24.1%)
0.507
5 (4.5%)
0.398
2/20 (10.0%)
0.608
46 (41.1%)
21 (42.0%)
25 (40.3%)
0.857
p value
5/22 (22.7%)
6/33 (18.2%)
0.467
Hirschsprungs disease
2/9 (22.2%)
3/15 (20.0%)
0.640
Jejunoileal atresia
7/9 (77.8%)
6/11 (54.5%)
0.272
Malrotation with
obstruction
3/7 (42.9%)
2/4 (50.0%)
0.651
Duodenal atresia
2/4 (50.0%)
2/6 (33.3%)
0.547
Obstructed hernia
2/4 (50.0%)
(25.0%)
0.500
21/55 (38.2%)
20/73 (27.4%)
0.195
Outcome
Overall, 87 (70.0%) neonates survived: 34 (61.8%) in
group A and 53 (72.6%) in group B. The causes of death
(n = 41) were infection (n = 25; 14 in group A, 11 in group
B), multiple congenital anomalies (n = 8; 4 in group A, 4
in group B), respiratory insufficiency (n = 7; 2 in group A,
5 in group B), anesthetic accident (n = 1 in group A).
Table 4 summarizes the causes and rates of mortality for
the two groups. For those that survived, the average
duration of hospital stay for the initial management was
23.7 days (range = 1036 days).
Discussion
This study suggests that there is an increase in the incidence of neonatal intestinal obstruction in our hospital.
This increase may indicate that more of these neonates are
presenting to tertiary centers for appropriate treatment.
This is a deviation from previous reports [4, 10] where
resource deficiency and ignorance compelled parents to
seek treatment for their children in an inappropriate place
like herbal homes. Improvements in socioeconomic status
and educational campaigns may have contributed to this
trend. Conversely, the change in incidence may represent a
true increase.
One of the factors responsible for poor outcome of NIO
in the previous reports from developing countries is late
presentation [4, 5]. Unarguably, in the present report late
presentation for treatment occurred in the two groups of
neonates, but it was more prominent in those managed in
123
2 (3.2%)
2/16 (12.5%)
Anorectal malformation
Total
3 (6.0%)
4/36 (11.1%)
p value
26 (23.2%)
Total
Group A
Group B (n = 62)
11/49 (22.4%)
Wound dehiscence
Anastomotic leak
Group A (n = 50)
2409
References
1. Touloukian RJ (1993) Diagnosis and treatment of jejunoileal
atresia. World J Surg 17:310317
2. de Silva NT, Young JA, Wales PW (2006) Understanding neonatal bowel obstruction: building knowledge to advance practice.
Neonatal Netw 25:303318
3. de la Hunt MN (2006) The acute abdomen in the newborn. Semin
Fetal Neonatal Med 11:191197
4. Adeyemi D (1989) Neonatal intestinal obstruction in a developing tropical country:patterns, problems, and prognosis. J Trop
Pediatr 35:6670
5. Ameh EA, Dogo PM, Nmadu PT (2001) Emergency neonatal
surgery in a developing country. Pediatr Surg Int 17:448451
6. Nasir GA, Rahma S, Kadim AH (2000) Neonatal intestinal
obstruction. East Mediterr Health J 6:187193
7. Barrack SM, Kyambi JM, Ndungu J, et al. (1993) Intestinal
atresia as seen and treated at Kenyatta National Hospital, Nairobi.
East Afr Med J 70:558564
8. Chirdan LB, Uba AF, Pam SD (2004) Intestinal atresia: management problems in a developing country. Pediatr Surg Int;
20:834837
9. Chowdhary SK, Chalapathi G, Narasimhan KL, et al. (2004) An
audit of neonatal colostomy for high anorectal malformation: the
developing world perspective. Pediatr Surg Int 20:111113
10. Ekenze SO, Ikechukwu RN, Oparaocha DC (2006) Surgically
correctable congenital anomalies: prospective analysis of management problems and outcome in a developing country. J Trop
Pediatr 52:126131
11. Sato S, Nishijima E, Muraji T, et al. (1998) Jejunoileal atresia: a
27- year experience. J Pediatr Surg 33:16331635
12. Rescorla FJ, Grosfeld JL (1985) Intestinal atresia and stenosis:
analysis of survival in 120 cases. Surgery 98:668676
13. Bagolan P, Nappo S, Trucchi A, et al. (1996) Neonatal intestinal
obstruction: reducing short-term complications by surgical
refinements. Eur J Pediatr Surg 6:354357
14. Dalla Vecchia LK, Grosfeld JL, West KW, et al. (1998) Intestinal
atresia and stenosis: a 25-year experience with 277 cases. Arch
Surg 133:490496
15. Reyes HM, Meller JL, Loeff D (1989) Neonatal intestinal
obstruction. Clin Perinatol 16:8596
123